220 related articles for article (PubMed ID: 30326403)
1. Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
Shrivastava SK; Sinha SK; Srivastava P; Tripathi PN; Sharma P; Tripathi MK; Tripathi A; Choubey PK; Waiker DK; Aggarwal LM; Dixit M; Kheruka SC; Gambhir S; Shankar S; Srivastava RK
Bioorg Chem; 2019 Feb; 82():211-223. PubMed ID: 30326403
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents.
Sinha SK; Shrivastava SK
Bioorg Med Chem; 2013 Sep; 21(17):5451-60. PubMed ID: 23810675
[TBL] [Abstract][Full Text] [Related]
3. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.
Tripathi PN; Srivastava P; Sharma P; Tripathi MK; Seth A; Tripathi A; Rai SN; Singh SP; Shrivastava SK
Bioorg Chem; 2019 Apr; 85():82-96. PubMed ID: 30605887
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of some new 4-aminopyridine derivatives in learning and memory.
Sinha SK; Shrivastava SK
Bioorg Med Chem Lett; 2013 May; 23(10):2984-9. PubMed ID: 23562059
[TBL] [Abstract][Full Text] [Related]
5. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
Anand P; Singh B
Bioorg Med Chem; 2012 Jan; 20(1):521-30. PubMed ID: 22172310
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors.
Meden A; Knez D; Malikowska-Racia N; Brazzolotto X; Nachon F; Svete J; Sałat K; Grošelj U; Gobec S
Eur J Med Chem; 2020 Dec; 208():112766. PubMed ID: 32919297
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
[TBL] [Abstract][Full Text] [Related]
10. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
11. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
Szymański P; Janik A; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
Shrivastava SK; Srivastava P; Upendra TVR; Tripathi PN; Sinha SK
Bioorg Med Chem; 2017 Feb; 25(4):1471-1480. PubMed ID: 28126439
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
Mostofi M; Mohammadi Ziarani G; Lashgari N
Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
[TBL] [Abstract][Full Text] [Related]
16. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
[TBL] [Abstract][Full Text] [Related]
17. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
18. Designing of promising medicinal scaffolds for Alzheimer's disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches.
Hassan M; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Shahzadi S; Raza H; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY; Malik A
Bioorg Chem; 2019 Oct; 91():103138. PubMed ID: 31446329
[TBL] [Abstract][Full Text] [Related]
19. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
